Business Description
LifeMD Inc
NAICS : 541519
SIC : 8099
ISIN : US53216B1044
Total Employee Number:
384Description
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.59 | |||||
Equity-to-Asset | 0.21 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | -0.59 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | -0.89 | |||||
Beneish M-Score | -2.52 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.8 | |||||
3-Year EBITDA Growth Rate | 69.2 | |||||
3-Year EPS without NRI Growth Rate | 42.5 | |||||
3-Year FCF Growth Rate | 71.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 16.5 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 28.77 | |||||
9-Day RSI | 35.67 | |||||
14-Day RSI | 40.81 | |||||
3-1 Month Momentum % | 18.84 | |||||
6-1 Month Momentum % | 25.81 | |||||
12-1 Month Momentum % | -68.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.04 | |||||
Quick Ratio | 0.98 | |||||
Cash Ratio | 0.7 | |||||
Days Inventory | 45.57 | |||||
Days Sales Outstanding | 18.66 | |||||
Days Payable | 278.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.1 | |||||
Shareholder Yield % | 6.88 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 86.09 | |||||
Operating Margin % | -10.04 | |||||
Net Margin % | 2.9 | |||||
EBITDA Margin % | -5.79 | |||||
FCF Margin % | -2.18 | |||||
OCF Margin % | 3.15 | |||||
ROE % | 73.6 | |||||
ROA % | 7.37 | |||||
ROIC % | -42.04 | |||||
3-Year ROIIC % | 380.6 | |||||
ROC (Joel Greenblatt) % | -248.43 | |||||
ROCE % | -117.78 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 84.1 | |||||
Forward PE Ratio | 2.3 | |||||
Price-to-Owner-Earnings | 40.07 | |||||
PS Ratio | 1.04 | |||||
PB Ratio | 13.14 | |||||
Price-to-Tangible-Book | 52.56 | |||||
Price-to-Operating-Cash-Flow | 32.12 | |||||
EV-to-EBIT | -9.13 | |||||
EV-to-EBITDA | -16.82 | |||||
EV-to-Revenue | 0.97 | |||||
EV-to-Forward-Revenue | 0.78 | |||||
EV-to-FCF | -44.7 | |||||
Price-to-GF-Value | 0.74 | |||||
Price-to-Median-PS-Value | 0.71 | |||||
Earnings Yield (Greenblatt) % | -10.95 | |||||
FCF Yield % | -1.93 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LFMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
LifeMD Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 179.633 | ||
| EPS (TTM) ($) | 0.05 | ||
| Beta | 2.3098 | ||
| 3-Year Sharpe Ratio | 0.66 | ||
| 3-Year Sortino Ratio | 1.45 | ||
| Volatility % | 79.38 | ||
| 14-Day RSI | 40.81 | ||
| 14-Day ATR ($) | 0.343609 | ||
| 20-Day SMA ($) | 4.641 | ||
| 12-1 Month Momentum % | -68.5 | ||
| 52-Week Range ($) | 2.56 - 13.625 | ||
| Shares Outstanding (Mil) | 48.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
LifeMD Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
LifeMD Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-17 16:30 | In 140 days | ||
| Third quarter earnings results for 2026 | 2026-11-17 | In 139 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-05 16:30 | In 36 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 | In 35 days | ||
| General meeting for 2026 | 2026-06-12 12:00 | 4.90 (-1.41%) | ||
| Guidance call for 2026 | 2026-05-20 | 4.30 (+2.14%) | ||
| LD Micro Invitational XVI Conference | 2026-05-19 09:00 | 4.24 (-2.97%) | ||
| First quarter earnings conference call for 2026 | 2026-05-06 16:30 | 5.13 (+0.79%) | ||
| First quarter earnings results for 2026 | 2026-05-06 | 5.13 (+0.79%) | ||
| Annual report for 2025 | 2026-03-10 | 3.12 (+4.00%) |
Show
Entries
LifeMD Inc Frequently Asked Questions
What is LifeMD Inc(LFMD)'s stock price today?
The current price of LFMD is $4.21. The 52 week high of LFMD is $13.63 and 52 week low is $2.56.
When is next earnings date of LifeMD Inc(LFMD)?
The next earnings date of LifeMD Inc(LFMD) is 2026-08-05 Est..
Does LifeMD Inc(LFMD) pay dividends? If so, how much?
LifeMD Inc(LFMD) does not pay dividend.
Guru Commentaries on NAS:LFMD
No articles.
Press Release
Articles on LifeMD Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers